Status:
COMPLETED
Caudal Ropivacaine With or Without Dexmedetomidine for Post Operative Analgesia
Lead Sponsor:
National Academy of Medical Sciences, Nepal
Conditions:
Ropivacaine
Infraumbilical Surgery
Eligibility:
All Genders
2-7 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the postoperative analgesic effects of caudal Ropivacaine with or without Dexmedetomidine in pediatric infraumbilical surgery. The main question\[s\] it ...
Detailed Description
Children have significant pain following surgery. It has been under-managed most of the time. Poorly controlled post-operative pain increases the morbidity. It leads to post-operative agitation, urina...
Eligibility Criteria
Inclusion
- Children of either sex aged 2-7 years
- ASA (American Society of Anesthesiologist) physical status I or II
- Patients undergoing elective infraumbilical surgeries
Exclusion
- History of neuromuscular or psychiatric disease
- Coagulation disorders
- Skin lesion at the site of injection
- Spine deformity
- History of developmental delay
- Allergy to study drugs
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05979558
Start Date
June 16 2020
End Date
December 10 2021
Last Update
August 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Academy of Medical Sciences (NAMS)
Kathmandu, Bagmati, Nepal, 44600